Ocugen signs letter of intent to buy Canadian pharmaceutical manufacturing plant

//Ocugen signs letter of intent to buy Canadian pharmaceutical manufacturing plant

Ocugen signs letter of intent to buy Canadian pharmaceutical manufacturing plant

A Chester County company working to bring the Covid-19 vaccine Covaxin to the United States has entered into a deal to buy a dormant manufacturing plant in Canada. Ocugen Inc. (NASDAQ: OCGN) of Malvern said Thursday it has signed a non-binding letter of intent with Liminal BioSciences Inc. to acquire its manufacturing site in Belleville, Ontario, for an undisclosed amount. This site, Ocugen said, would enable it to expand manufacturing and research and development activities to support its pipeline…

Article by [author-name] (c) Health Care News - Health Care News Headlines | Bizjournals.com - Read full story here.

By | 2022-01-27T19:05:43+00:00 January 27th, 2022|Healthcare|

About the Author: